X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
glatiramer acetate (480) 480
science & technology (407) 407
life sciences & biomedicine (379) 379
humans (340) 340
multiple sclerosis (332) 332
peptides - pharmacology (192) 192
multiple sclerosis - drug therapy (190) 190
peptides - therapeutic use (188) 188
neurosciences & neurology (174) 174
pharmacology & pharmacy (172) 172
animals (170) 170
female (169) 169
neurosciences (147) 147
male (128) 128
adult (116) 116
immunosuppressive agents - pharmacology (114) 114
immunosuppressive agents - therapeutic use (111) 111
immunology (106) 106
clinical neurology (101) 101
interferon-beta - therapeutic use (89) 89
mice (88) 88
neurology (82) 82
multiple sclerosis - immunology (80) 80
middle aged (79) 79
multiple sclerosis, relapsing-remitting - drug therapy (78) 78
drug therapy (70) 70
adjuvants, immunologic - therapeutic use (60) 60
medicine & public health (59) 59
treatment outcome (58) 58
analysis (51) 51
immunologic factors - therapeutic use (51) 51
peptides - administration & dosage (49) 49
cells, cultured (48) 48
copolymer 1 (48) 48
interferon (48) 48
care and treatment (44) 44
interferon beta (44) 44
glatiramer acetate - pharmacology (43) 43
glatiramer acetate - therapeutic use (42) 42
research (42) 42
disease progression (41) 41
natalizumab (41) 41
t-lymphocytes - immunology (41) 41
t cells (40) 40
disease models, animal (39) 39
biological response modifiers (38) 38
pharmacotherapy (38) 38
magnetic resonance imaging (37) 37
mice, inbred c57bl (37) 37
time factors (37) 37
copaxone (36) 36
multiple sclerosis - pathology (36) 36
adjuvants, immunologic - pharmacology (35) 35
encephalomyelitis, autoimmune, experimental - drug therapy (35) 35
interferon beta-1a (35) 35
rats (35) 35
t-lymphocytes - drug effects (34) 34
cytokines - metabolism (33) 33
immunosuppressive agents - administration & dosage (33) 33
peptides - adverse effects (33) 33
health aspects (32) 32
multiple sclerosis - physiopathology (32) 32
psychiatry (32) 32
immunotherapy (31) 31
abridged index medicus (30) 30
cytokines (30) 30
interferon beta-1b (30) 30
multiple sclerosis, relapsing-remitting - immunology (30) 30
science & technology - other topics (30) 30
inflammation (29) 29
internal medicine (29) 29
neuroprotection (29) 29
allergy and immunology (28) 28
encephalomyelitis, autoimmune, experimental - immunology (28) 28
immunologic factors - pharmacology (28) 28
immunomodulation (28) 28
interferon-beta - pharmacology (28) 28
multidisciplinary sciences (28) 28
pharmacology/toxicology (28) 28
acetates (27) 27
clinical trials (27) 27
immunosuppressive agents - adverse effects (27) 27
multiple sclerosis - therapy (27) 27
dosage and administration (25) 25
fingolimod (25) 25
clinical trials as topic (24) 24
interferon-beta - administration & dosage (24) 24
mice, inbred balb c (24) 24
peptides - immunology (24) 24
psychopharmacology (24) 24
recurrence (24) 24
lymphocyte activation - drug effects (23) 23
neuroprotective agents - pharmacology (23) 23
development and progression (22) 22
patients (22) 22
studies (22) 22
young adult (22) 22
experimental autoimmune encephalomyelitis (21) 21
lymphocytes (21) 21
mice, transgenic (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (547) 547
Spanish (5) 5
Chinese (3) 3
Hungarian (2) 2
Japanese (2) 2
Russian (2) 2
German (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European journal of pharmaceutical sciences, ISSN 0928-0987, 05/2019, Volume 133, pp. 8 - 14
...), complexity may arise either from the active substance, as in the case of glatiramer acetate, or from other sources, such as the formulation, as in the case of liposomes... 
NBCD | Complex drug | Glatiramer | Glatiramoid | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Glatiramer acetate | Generic drugs | Independent regulatory commissions | Chemical synthesis
Journal Article
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 12/2005, Volume 102, Issue 52, pp. 19045 - 19050
.... Their expression in the CNS after various insults is thus of major therapeutic consequence. Glatiramer acetate [(GA) Copaxone... 
T lymphocytes | Biological Sciences | Nervous system diseases | Messenger RNA | Cytokines | Neurons | Central nervous system | Cell lines | Central nervous system diseases | Chronic diseases | Mice | NT-3 | NT-4 | Neurotrophins | BDNF | Immunomodulation | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Immunohistochemistry | Central Nervous System - metabolism | Encephalomyelitis, Autoimmune, Experimental - immunology | Glatiramer Acetate | Neurons - cytology | Nerve Growth Factors - metabolism | Stem Cells - metabolism | Brain - metabolism | In Situ Hybridization | Neuroprotective Agents - pharmacology | Time Factors | Female | Brain-Derived Neurotrophic Factor - metabolism | Neurons - metabolism | Immunosuppressive Agents - pharmacology | Disease Models, Animal | Astrocytes - cytology | Anti-Inflammatory Agents - pharmacology | Cell Survival | Mice, Inbred C57BL | Myelin-Oligodendrocyte Glycoprotein | Reverse Transcriptase Polymerase Chain Reaction | Peptides - pharmacology | Animals | Neurotrophin 3 - metabolism | T-Lymphocytes - cytology | Myelin-Associated Glycoprotein - chemistry | Brain - pathology | Myelin Proteins | Polymers - chemistry | Mice, Inbred BALB C | Immunosuppressive Agents - chemistry | Encephalomyelitis | Health aspects | Rodents as pets | Index Medicus | immunomodulation | neurotrophins
Journal Article
Journal Article
Journal Article
Neurotherapeutics, ISSN 1933-7213, 1/2013, Volume 10, Issue 1, pp. 2 - 18
Interferon beta and glatiramer acetate have been mainstays of treatment in relapsingremitting multiple sclerosis for two decades... 
Glatiramer acetate | Neurology | Neurosciences | Biomedicine | Neurobiology |